CIK: 0001388551 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value ($000): $74,436 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| USO | UNITED STS OIL FD LP | 353,500 | $28,404 | 38.2% | — | — | Call | 91232N207 |
| SVRA | SAVARA INC | 6,896,551 | $10,483 | 14.1% | $1.66 | -21.0% | COM | 805111101 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 6,039,028 | $9,300 | 12.5% | $2.16 | -2.3% | COM | 98422E103 |
| GLD | SPDR GOLD TR | 40,820 | $6,877 | 9.2% | $173.82 | — | GOLD SHS | 78463V107 |
| SPY | SPDR S&P 500 ETF TR | 15,947 | $6,016 | 8.1% | $451.81 | — | TR UNIT | 78462F103 |
| RZLT | REZOLUTE INC | 1,403,157 | $4,532 | 6.1% | $9.52 | -65.1% | COM NEW | 76200L309 |
| SCYX | SCYNEXIS INC | 1,723,947 | $3,207 | 4.3% | $6.13 | -60.8% | COM NEW | 811292200 |
| — | MOLECULAR TEMPLATES INC | 2,052,991 | $1,872 | 2.5% | $8.09 | — | COM | 608550109 |
| ACLX | ARCELLX INC | 101,719 | $1,839 | 2.5% | $16.24 | -20.5% | COMMON STOCK | 03940C100 |
| — | VECTIVBIO HLDG AG | 194,577 | $1,051 | 1.4% | $5.40 | — | ORD SHS | H9060V101 |
| — | EIGER BIOPHARMACEUTICALS INC | 116,884 | $736 | 1.0% | $9.18 | — | COM | 28249U105 |
| — | ELEVATION ONCOLOGY INC | 68,293 | $96 | 0.1% | $9.95 | — | COM | 28623U101 |
| — | BRIDGETOWN HOLDINGS LTD | 39,773 | $10 | 0.0% | $4.40 | — | *W EXP 09/30/202 | G1355U121 |
| — | LUX HEALTH TECH ACQUISITION | 66,666 | $9 | 0.0% | $1.49 | — | *W EXP 11/30/202 | 55068A118 |
| — | FRAZIER LIFESCIENCES ACQU CO | 21,333 | $2 | 0.0% | $0.89 | — | *W EXP 11/30/202 | G3710A113 |
| — | PRIMAVERA CAPITAL ACQUIST CO | 12,000 | $2 | 0.0% | $0.83 | — | *W EXP 01/19/202 | G7255E117 |